Use of a Cholera Rapid Diagnostic Test during a Mass Vaccination Campaign in Response to an Epidemic in Guinea, 2012

Isabel Martinez-Pino, Francisco J. Luquero, Kéïta Sakoba, Souleymane Sylla, Melatwork Haile, Rebecca F. Grais, Iza Ciglenecki, Marie Laure Quilici, Anne Laure Page

Research output: Contribution to journalArticle

Abstract

Background:During the 2012 cholera outbreak in the Republic of Guinea, the Ministry of Health, supported by Médecins Sans Frontières - Operational Center Geneva, used the oral cholera vaccine Shanchol as a part of the emergency response. The rapid diagnostic test (RDT) Crystal VC, widely used during outbreaks, detects lipopolysaccharide antigens of Vibrio cholerae O1 and O139, both included in Shanchol. In the context of reactive use of a whole-cell cholera vaccine in a region where cholera cases have been reported, it is essential to know what proportion of vaccinated individuals would be reactive to the RDT and for how long after vaccination.Methodology/Principal Findings:A total of 108 vaccinated individuals, selected systematically among all persons older than one year, were included at vaccination sites and 106 were included in the analysis. Stools samples of this cohort of vaccinated participants were collected and tested with the RDT every day until the test was negative for two consecutive visits or for a maximum of 7 days. A total of 94.3% of cholera vaccine recipients had a positive test after vaccination; all except one of these positive results were reactive only with the O139 antigen. The mean time to become negative in those with an initial positive result after vaccination was 3.8 days, standard deviation 1.1 days.Conclusions/Significance:The RDT Crystal VC becomes positive in persons recently vaccinated against cholera, although almost exclusively to the O139 antigen. This reactivity largely disappeared within five days after vaccination. These results suggest that the test can be used normally as soon as 24 hours after vaccination in a context of O1 epidemics, which represent the vast majority of cases, and after a period of five days in areas where V. cholerae O139 is present. The reason why only O139 test line became positive remains to be investigated.

Original languageEnglish (US)
Article numbere2366
JournalPLoS Neglected Tropical Diseases
Volume7
Issue number8
DOIs
StatePublished - Aug 2013
Externally publishedYes

Fingerprint

Guinea
Mass Vaccination
Immunization Programs
Cholera
Routine Diagnostic Tests
Vaccination
Cholera Vaccines
Vibrio cholerae O139
Antigens
Disease Outbreaks
Vibrio cholerae O1
Lipopolysaccharides
Emergencies
Health

ASJC Scopus subject areas

  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Use of a Cholera Rapid Diagnostic Test during a Mass Vaccination Campaign in Response to an Epidemic in Guinea, 2012. / Martinez-Pino, Isabel; Luquero, Francisco J.; Sakoba, Kéïta; Sylla, Souleymane; Haile, Melatwork; Grais, Rebecca F.; Ciglenecki, Iza; Quilici, Marie Laure; Page, Anne Laure.

In: PLoS Neglected Tropical Diseases, Vol. 7, No. 8, e2366, 08.2013.

Research output: Contribution to journalArticle

Martinez-Pino, I, Luquero, FJ, Sakoba, K, Sylla, S, Haile, M, Grais, RF, Ciglenecki, I, Quilici, ML & Page, AL 2013, 'Use of a Cholera Rapid Diagnostic Test during a Mass Vaccination Campaign in Response to an Epidemic in Guinea, 2012', PLoS Neglected Tropical Diseases, vol. 7, no. 8, e2366. https://doi.org/10.1371/journal.pntd.0002366
Martinez-Pino, Isabel ; Luquero, Francisco J. ; Sakoba, Kéïta ; Sylla, Souleymane ; Haile, Melatwork ; Grais, Rebecca F. ; Ciglenecki, Iza ; Quilici, Marie Laure ; Page, Anne Laure. / Use of a Cholera Rapid Diagnostic Test during a Mass Vaccination Campaign in Response to an Epidemic in Guinea, 2012. In: PLoS Neglected Tropical Diseases. 2013 ; Vol. 7, No. 8.
@article{3d541711eaf645e29838869ae2242f19,
title = "Use of a Cholera Rapid Diagnostic Test during a Mass Vaccination Campaign in Response to an Epidemic in Guinea, 2012",
abstract = "Background:During the 2012 cholera outbreak in the Republic of Guinea, the Ministry of Health, supported by M{\'e}decins Sans Fronti{\`e}res - Operational Center Geneva, used the oral cholera vaccine Shanchol as a part of the emergency response. The rapid diagnostic test (RDT) Crystal VC, widely used during outbreaks, detects lipopolysaccharide antigens of Vibrio cholerae O1 and O139, both included in Shanchol. In the context of reactive use of a whole-cell cholera vaccine in a region where cholera cases have been reported, it is essential to know what proportion of vaccinated individuals would be reactive to the RDT and for how long after vaccination.Methodology/Principal Findings:A total of 108 vaccinated individuals, selected systematically among all persons older than one year, were included at vaccination sites and 106 were included in the analysis. Stools samples of this cohort of vaccinated participants were collected and tested with the RDT every day until the test was negative for two consecutive visits or for a maximum of 7 days. A total of 94.3{\%} of cholera vaccine recipients had a positive test after vaccination; all except one of these positive results were reactive only with the O139 antigen. The mean time to become negative in those with an initial positive result after vaccination was 3.8 days, standard deviation 1.1 days.Conclusions/Significance:The RDT Crystal VC becomes positive in persons recently vaccinated against cholera, although almost exclusively to the O139 antigen. This reactivity largely disappeared within five days after vaccination. These results suggest that the test can be used normally as soon as 24 hours after vaccination in a context of O1 epidemics, which represent the vast majority of cases, and after a period of five days in areas where V. cholerae O139 is present. The reason why only O139 test line became positive remains to be investigated.",
author = "Isabel Martinez-Pino and Luquero, {Francisco J.} and K{\'e}{\"i}ta Sakoba and Souleymane Sylla and Melatwork Haile and Grais, {Rebecca F.} and Iza Ciglenecki and Quilici, {Marie Laure} and Page, {Anne Laure}",
year = "2013",
month = "8",
doi = "10.1371/journal.pntd.0002366",
language = "English (US)",
volume = "7",
journal = "PLoS Neglected Tropical Diseases",
issn = "1935-2727",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Use of a Cholera Rapid Diagnostic Test during a Mass Vaccination Campaign in Response to an Epidemic in Guinea, 2012

AU - Martinez-Pino, Isabel

AU - Luquero, Francisco J.

AU - Sakoba, Kéïta

AU - Sylla, Souleymane

AU - Haile, Melatwork

AU - Grais, Rebecca F.

AU - Ciglenecki, Iza

AU - Quilici, Marie Laure

AU - Page, Anne Laure

PY - 2013/8

Y1 - 2013/8

N2 - Background:During the 2012 cholera outbreak in the Republic of Guinea, the Ministry of Health, supported by Médecins Sans Frontières - Operational Center Geneva, used the oral cholera vaccine Shanchol as a part of the emergency response. The rapid diagnostic test (RDT) Crystal VC, widely used during outbreaks, detects lipopolysaccharide antigens of Vibrio cholerae O1 and O139, both included in Shanchol. In the context of reactive use of a whole-cell cholera vaccine in a region where cholera cases have been reported, it is essential to know what proportion of vaccinated individuals would be reactive to the RDT and for how long after vaccination.Methodology/Principal Findings:A total of 108 vaccinated individuals, selected systematically among all persons older than one year, were included at vaccination sites and 106 were included in the analysis. Stools samples of this cohort of vaccinated participants were collected and tested with the RDT every day until the test was negative for two consecutive visits or for a maximum of 7 days. A total of 94.3% of cholera vaccine recipients had a positive test after vaccination; all except one of these positive results were reactive only with the O139 antigen. The mean time to become negative in those with an initial positive result after vaccination was 3.8 days, standard deviation 1.1 days.Conclusions/Significance:The RDT Crystal VC becomes positive in persons recently vaccinated against cholera, although almost exclusively to the O139 antigen. This reactivity largely disappeared within five days after vaccination. These results suggest that the test can be used normally as soon as 24 hours after vaccination in a context of O1 epidemics, which represent the vast majority of cases, and after a period of five days in areas where V. cholerae O139 is present. The reason why only O139 test line became positive remains to be investigated.

AB - Background:During the 2012 cholera outbreak in the Republic of Guinea, the Ministry of Health, supported by Médecins Sans Frontières - Operational Center Geneva, used the oral cholera vaccine Shanchol as a part of the emergency response. The rapid diagnostic test (RDT) Crystal VC, widely used during outbreaks, detects lipopolysaccharide antigens of Vibrio cholerae O1 and O139, both included in Shanchol. In the context of reactive use of a whole-cell cholera vaccine in a region where cholera cases have been reported, it is essential to know what proportion of vaccinated individuals would be reactive to the RDT and for how long after vaccination.Methodology/Principal Findings:A total of 108 vaccinated individuals, selected systematically among all persons older than one year, were included at vaccination sites and 106 were included in the analysis. Stools samples of this cohort of vaccinated participants were collected and tested with the RDT every day until the test was negative for two consecutive visits or for a maximum of 7 days. A total of 94.3% of cholera vaccine recipients had a positive test after vaccination; all except one of these positive results were reactive only with the O139 antigen. The mean time to become negative in those with an initial positive result after vaccination was 3.8 days, standard deviation 1.1 days.Conclusions/Significance:The RDT Crystal VC becomes positive in persons recently vaccinated against cholera, although almost exclusively to the O139 antigen. This reactivity largely disappeared within five days after vaccination. These results suggest that the test can be used normally as soon as 24 hours after vaccination in a context of O1 epidemics, which represent the vast majority of cases, and after a period of five days in areas where V. cholerae O139 is present. The reason why only O139 test line became positive remains to be investigated.

UR - http://www.scopus.com/inward/record.url?scp=84883331780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883331780&partnerID=8YFLogxK

U2 - 10.1371/journal.pntd.0002366

DO - 10.1371/journal.pntd.0002366

M3 - Article

C2 - 23967359

AN - SCOPUS:84883331780

VL - 7

JO - PLoS Neglected Tropical Diseases

JF - PLoS Neglected Tropical Diseases

SN - 1935-2727

IS - 8

M1 - e2366

ER -